A detailed history of Lmr Partners LLP transactions in Exact Sciences Corp stock. As of the latest transaction made, Lmr Partners LLP holds 177,200 shares of EXAS stock, worth $10.2 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
177,200
Holding current value
$10.2 Million
% of portfolio
0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$42.43 - $70.83 $2.95 Million - $4.92 Million
69,412 New
69,412 $4.73 Million
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $1.33 Million - $2 Million
20,175 New
20,175 $1.38 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $1.75 Million - $2.69 Million
54,587 New
54,587 $1.77 Million
Q2 2022

Aug 15, 2022

SELL
$35.61 - $76.23 $5.32 Million - $11.4 Million
-149,428 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$57.56 - $82.54 $840,836 - $1.21 Million
14,608 Added 10.84%
149,428 $10.4 Million
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $2.23 Million - $3.1 Million
30,765 Added 29.57%
134,820 $10.5 Million
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $9.39 Million - $12.9 Million
104,055 New
104,055 $9.93 Million
Q1 2020

May 15, 2020

SELL
$37.9 - $104.44 $2.3 Million - $6.34 Million
-60,750 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $4.72 Million - $6.06 Million
60,750 New
60,750 $5.62 Million
Q2 2019

Aug 14, 2019

SELL
$89.51 - $118.04 $4.37 Million - $5.77 Million
-48,852 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $3.03 Million - $4.71 Million
48,852 New
48,852 $4.23 Million
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $2.67 Million - $3.94 Million
-47,702 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $6.92 Million - $11.5 Million
-143,280 Reduced 75.02%
47,702 $3.77 Million
Q2 2018

Aug 03, 2018

BUY
$37.84 - $69.96 $7.23 Million - $13.4 Million
190,982 New
190,982 $11.4 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.